Gordon Tunstall - May 14, 2021 Form 4 Insider Report for Tabula Rasa HealthCare, Inc. (TRHC)

Role
Director
Signature
/s/ Brian W. Adams, by Power of Attorney
Stock symbol
TRHC
Transactions as of
May 14, 2021
Transactions value $
-$382,825
Form type
4
Date filed
5/18/2021, 05:36 PM
Next filing
May 20, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TRHC Common Stock Options Exercise $5.13K +3.29K +24.5% $1.56* 16.7K May 14, 2021 Direct
transaction TRHC Common Stock Options Exercise $24.1K +6.71K +40.17% $3.59 23.4K May 14, 2021 Direct
transaction TRHC Common Stock Sale -$206K -5K -21.35% $41.22 18.4K May 14, 2021 Direct F1, F2
transaction TRHC Common Stock Sale -$206K -5K -27.14% $41.19 13.4K May 14, 2021 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TRHC Employee Stock Option (right to buy) Options Exercise $0 -3.29K -100% $0.00* 0 May 14, 2021 Common Stock 3.29K $1.56 Direct F4
transaction TRHC Employee Stock Option (right to buy) Options Exercise $0 -6.71K -26.04% $0.00 19.1K May 14, 2021 Common Stock 6.71K $3.59 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2020.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $41.00 to $41.12, inclusive. The reporting person undertakes to provide to Tabula Rasa HealthCare, Inc., any security holder of Tabula Rasa HealthCare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in footnotes (2) and (3) to this Form 4.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $41.20 to $41.39, inclusive.
F4 The stock option vested 25% on March 21, 2013 and in equal 1/36th installments each month thereafter.
F5 The stock option vested 25% on November 19, 2014 and in equal 1/36th installments each month thereafter.